Tag: JR Rahn

July 29, 2020

VIDEO — MindMed CEO: Psychedelics to Redefine How Mental Health is Addressed

INN chatted with JR Rahn, co-CEO of MindMed, about the impact going public has had on the company and where...
July 16, 2020

Psychedelics Make an Impression at Prohibition Partners LIVE

Curious investors were able to hear firsthand about the burgeoning psychedelics industry during the first Prohibition Partners LIVE event.
June 23, 2020

Ways to Invest in Psychedelics

As this exciting new drug market continues to attract capital, investors are starting to ask about ways to invest in...
March 3, 2020

Psychedelics Listing Makes Debut on the NEO

Mind Medicine made its official public debut on the NEO Exchange, becoming the first psychedelics medicine firm on the up...